journal article·2025-10Open access

Vascularized in vitro bone model as 3D quadruple culture with primary human osteoblasts, osteocytes, osteoclasts and endothelial cells

Katharina Wirsig, Nina Bürger, Lisa Fleischhauer, Nele Louisa Preuß, Anne Bernhardt

Abstract

With an aging population worldwide, research into bone metabolism and novel therapies for damaged and diseased bone is essential. Bone is a vascularized, dynamic tissue that undergoes a constant remodeling process mediated by osteocytes, osteoblasts and osteoclasts. In this study, a complex 3D in vitro bone model combining these three main bone cell species with endothelial cells was developed. The different cell species were isolated from primary human tissue and spatially arranged using transwell inserts. Osteocytes differentiated from collagen-embedded osteoblasts, while osteoclasts simultaneously derived from peripheral blood mononuclear cells without receptor activator of NF-κB ligand (RANKL) supplementation. Different cultivation parameters were evaluated to define conditions that support differentiation and function of all cell types involved in quadruple culture. The cellular crosstalk in quadruple cultures stimulated osteoblast (ALP, BMP-2, IBSP, COL1A, VEGF) and osteocyte (SOST, DMP1) markers, while osteoclast (TRAP) and endothelial cell markers were reduced compared to respective mono- or co-cultures. Furthermore, mineralization was induced only in quadruple cultures, demonstrating the importance of signaling between the four cell types. This sophisticated human bone model provides a physiologically relevant culture system to study the complex crosstalk between bone cells, their precursors and endothelial cells during remodeling and vascularization. Moreover, it allows preclinical testing of bioactive factors, biomaterial extracts or drugs for translation into clinical practice without animal testing. • Simultaneous differentiation of osteocytes and osteoclasts without RANKL supplementation. • Osteogenesis, osteoclastogenesis, vascularization and mineralization in parallel. • Osteocyte differentiation is upregulated by BMP-2 (MEPE, SOST, DMP1). • Crosstalk in quadruple culture stimulated osteoblast markers and mineralization. • Crosstalk in quadruple culture stimulated osteocyte markers (SOST, DMP1).
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · 3D Printing in Biomedical Research · Bone Metabolism and Diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (76)

Show source-provided references
1. Osteocytes: master orchestrators of bone10.1007/s00223-013-9790-y ↗
2. The amazing osteocyte10.1002/jbmr.320 ↗
3. Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway10.1371/journal.pone.0025900 ↗
4. RANKL biology: bone metabolism, the immune system, and beyond10.1186/s41232-019-0111-3 ↗
5. Functions of RANKL/RANK/OPG in bone modeling and remodeling10.1016/j.abb.2008.03.018 ↗
6. Fundamentals of bone vasculature: specialization, interactions and functions10.1016/j.semcdb.2021.06.025 ↗
7. The role of vasculature in bone development, regeneration and proper systemic functioning10.1007/s10456-017-9541-1 ↗
8. Osteoblast-derived VEGF regulates osteoblast differentiation and bone formation during bone repair10.1172/JCI82585 ↗
9. Osteocyte-induced angiogenesis via VEGF–MAPK-dependent pathways in endothelial cells10.1007/s11010-013-1840-2 ↗
10. Regulation of osteogenesis-angiogenesis coupling by HIFs and VEGF10.1359/jbmr.090602 ↗
11. Hypoxia increases Annexin A2 expression in osteoblastic cells via VEGF and ERK10.1016/j.bone.2010.08.024 ↗
12. Notch signaling in vascular endothelial cells, angiogenesis, and tumor progression: an update and prospective10.3389/fcell.2021.642352 ↗
13. Notch regulation of bone development and remodeling and related skeletal disorders10.1007/s00223-011-9541-x ↗
14. Notch signaling in osteocytes differentially regulates cancellous and cortical bone remodeling10.1074/jbc.M113.470492 ↗
15. Notch signaling pathway enhances bone morphogenetic protein 2 (BMP2) responsiveness of Msx2 gene to induce osteogenic differentiation and mineralization of vascular smooth muscle cells10.1074/jbc.M110.175786 ↗
16. Notch and the regulation of osteoclast differentiation and function10.1016/j.bone.2020.115474 ↗
17. Mechanical loading activates the YAP/TAZ pathway and chemokine expression in the MLO-Y4 osteocyte-like cell line10.1038/s41374-021-00668-5 ↗
18. Extracellular matrix mineralization in murine MC3T3-E1 osteoblast cultures: an ultrastructural, compositional and comparative analysis with mouse bone10.1016/j.bone.2014.11.003 ↗
19. Effect of MC3T3 cell density on osteoclastic differentiation of mouse bone marrow cells10.1016/j.tice.2021.101724 ↗
20. Modulation of alendronate release from a calcium phosphate bone cement: an in vitro osteoblast-osteoclast co-culture study10.1016/j.ijpharm.2018.11.023 ↗
21. Reciprocal osteoblastic and osteoclastic modulation in co-cultured MG63 osteosarcoma cells and human osteoclast precursors10.1002/jcb.23295 ↗
22. Evaluation of culture conditions for osteoclastogenesis in RAW264.7 cells10.1371/journal.pone.0277871 ↗
23. Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties
24. G.-I. Kontogianni, K. Loukelis, A.F. Bonatti, E. Batoni, C. De Maria, G. Vozzi, R. Naseem, K. Dalgarno, H. Shin, C. Vitale-Brovarone, M. Chatzinikolaidou, A mechanically stimulated Co-culture in 3-Dimensional composite scaffolds promotes osteogenic and anti-osteoclastogenic activity and M2 macrophage polarization, Biomater. Res. 29 (n.d.) 135. https://doi.org/10.34133/bmr.0135.10.34133/bmr.0135 ↗
25. In vitro Co-culture model of primary human osteoblasts and osteocytes in collagen gels10.3390/ijms20081998 ↗
26. Co–culture systems of osteoblasts and osteoclasts: simulating in vitro bone remodeling in regenerative approaches10.1016/j.actbio.2020.03.043 ↗
27. Cellular response of advanced triple cultures of human osteocytes, osteoblasts and osteoclasts to high sulfated hyaluronan (sHA3)
28. A 3D vascularized bone remodeling model combining osteoblasts and osteoclasts in a CaP nanoparticle-enriched matrix10.2217/nnm-2015-0021 ↗
29. An improved method to isolate primary human osteocytes from bone10.1515/bmt-2018-0185 ↗
30. Triple culture of primary human osteoblasts, osteoclasts and osteocytes as an in vitro bone model10.3390/ijms22147316 ↗
31. Influence of Cu2+ on osteoclast formation and activity in vitro10.3390/ijms22052451 ↗
32. Primary human osteocyte networks in pure and modified collagen gels10.1089/ten.tea.2018.0338 ↗
33. Optimization of culture conditions for osteogenically-induced mesenchymal stem cells in β-tricalcium phosphate ceramics with large interconnected channels10.1002/term.331 ↗
34. Relevance of osteoclast-specific enzyme activities in cell-based in vitro resorption assays10.22203/eCM.v033a03 ↗
35. Critical role of hypoxia sensor--HIF-1α in VEGF gene activation. Implications for angiogenesis and tissue injury healing10.2174/092986712803413944 ↗
36. Hypoxia induces upregulation of VEGF-C and lymphatic differentiation via Hif-1a pathway10.1016/j.jamcollsurg.2009.06.175 ↗
37. Development and characterization of a high-throughput in vitro cord formation model insensitive to VEGF inhibition10.1186/1756-8722-6-31 ↗
38. Hypoxia damages endothelial cell angiogenic function by reducing the Ca2+ restoring ability of the endoplasmic reticulum10.1016/j.bbrc.2022.07.105 ↗
39. Hypoxia destroys the microstructure of microtubules and causes dysfunction of endothelial cells via the PI3K/Stathmin1 pathway10.1186/s13578-019-0283-1 ↗
40. Effect of oxidative stress on bone remodeling in periprosthetic osteolysis10.1007/s12018-021-09278-7 ↗
41. Reactive oxygen species and oxidative stress in osteoclastogenesis, skeletal aging and bone diseases10.1007/s00774-015-0656-4 ↗
42. Insights into oxidative stress in bone tissue and novel challenges for biomaterials10.1016/j.msec.2021.112433 ↗
43. Hypoxia inhibits the growth, differentiation and bone-forming capacity of rat osteoblasts10.1016/j.yexcr.2006.02.007 ↗
44. Impact of Sr2+ and hypoxia on 3D triple cultures of primary human osteoblasts, osteocytes and osteoclasts10.1016/j.ejcb.2022.151256 ↗
45. Hypoxia inhibits the spontaneous calcification of bone marrow-derived mesenchymal stem cells10.1002/jcb.24014 ↗
46. Hypoxia inhibits osteogenesis in human mesenchymal stem cells through direct regulation of RUNX2 by TWIST
47. Hypoxia inhibits osteogenesis in human mesenchymal stem cells through direct regulation of RUNX2 by TWIST
48. Effects of vascular endothelial growth factor (VEGF) on MC3T3-E110.1111/j.1601-6343.2010.01498.x ↗
49. Vascular endothelial growth factor stimulates osteoblastic differentiation of cultured human periosteal-derived cells expressing vascular endothelial growth factor receptors10.1007/s11033-010-0249-1 ↗
50. Effects of vascular endothelial growth factor on osteoblasts around dental implants in vitro and in vivo10.2334/josnusd.16-0406 ↗
51. Effect of hypoxia on the expression of RANKL/OPG in human periodontal ligament cells in vitro
52. Hypoxia-inducible factor 1α enhances RANKL-induced osteoclast differentiation by upregulating the MAPK pathway10.21037/atm-22-4603 ↗
53. Osteoblast hypoxia-inducible Factor-1α pathway activation restrains osteoclastogenesis via the Interleukin-33-MicroRNA-34a-Notch1 pathway10.3389/fimmu.2017.01312 ↗
54. Constant hypoxia inhibits osteoclast differentiation and bone resorption by regulating phosphorylation of JNK and IκBα10.1007/s00011-018-1209-9 ↗
55. Impacts of hypoxia on osteoclast formation and activity: systematic review10.3390/ijms221810146 ↗
56. Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts10.1016/S0014-5793(00)01520-9 ↗
57. VEGF enhancement of osteoclast survival and bone resorption involves VEGF receptor-2 signaling and beta3-integrin10.1016/j.matbio.2008.06.005 ↗
58. Oxygen tension is an important mediator of the transformation of osteoblasts to osteocytes10.1007/s00774-007-0765-9 ↗
59. Hypoxia induces BMP-2 expression via ILK, Akt, mTOR, and HIF-1 pathways in osteoblasts10.1002/jcp.22104 ↗
60. Bone morphogenetic Protein-2 in development and bone homeostasis10.3390/jdb8030019 ↗
61. BMP-2 long-term stimulation of human pre-osteoblasts induces osteogenic differentiation and promotes transdifferentiation and bone remodeling processes10.3390/ijms23063077 ↗
62. BMP‐2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop10.1359/jbmr.2003.18.10.1842 ↗
63. Bone morphogenetic protein 2-induced human dental pulp cell differentiation involves p38 mitogen-activated protein kinase-activated canonical WNT pathway10.1038/ijos.2015.7 ↗
64. Modulation of sclerostin expression by mechanical loading and bone morphogenetic proteins in osteogenic cells
65. Sclerostin expression is induced by BMPs in human Saos-2 osteosarcoma cells but not via direct effects on the sclerostin gene promoter or ECR5 element10.1016/j.bone.2011.08.016 ↗
66. Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles?10.1007/s00198-014-2808-0 ↗
67. Recombinant sclerostin inhibits bone formation in vitro and in a mouse model of sclerosteosis10.1016/j.jot.2021.05.005 ↗
68. Osteocyte-derived sclerostin inhibits bone formation: its role in bone morphogenetic protein and Wnt signaling10.2106/JBJS.G.01183 ↗
69. Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway10.1371/journal.pone.0025900 ↗
70. Osteoblast-osteoclast communication and bone homeostasis10.3390/cells9092073 ↗
71. Communication between endothelial cells and osteoblasts in regulation of bone homeostasis: notch players10.1186/s13287-025-04176-x ↗
72. Up-regulation of alkaline phosphatase expression in human primary osteoblasts by cocultivation with primary endothelial cells is mediated by p38 mitogen-activated protein kinase-dependent mRNA stabilization10.1089/ten.tea.2009.0133 ↗
73. Endothelial-mesenchymal crosstalk drives osteogenic differentiation of human osteoblasts through notch signaling10.1186/s12964-025-02096-0 ↗
74. Generation of complex bone marrow organoids from human induced pluripotent stem cells10.1038/s41592-024-02172-2 ↗
75. Synthetic biodegradable microporous hydrogels for in vitro 3D culture of functional human bone cell networks10.1038/s41467-024-49280-3 ↗
76. Engineering the early bone metastatic niche through human vascularized immuno bone minitissues10.1088/1758-5090/abefea ↗